[1]
Tai YF, Piccini P. Applications of positron emission tomography (PET) in neurology. Journal of neurology, neurosurgery, and psychiatry. 2004 May:75(5):669-76
[PubMed PMID: 15090557]
[2]
Reivich M, Kuhl D, Wolf A, Greenberg J, Phelps M, Ido T, Casella V, Fowler J, Hoffman E, Alavi A, Som P, Sokoloff L. The [18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man. Circulation research. 1979 Jan:44(1):127-37
[PubMed PMID: 363301]
Level 3 (low-level) evidence
[3]
Newberg A, Alavi A, Reivich M. Determination of regional cerebral function with FDG-PET imaging in neuropsychiatric disorders. Seminars in nuclear medicine. 2002 Jan:32(1):13-34
[PubMed PMID: 11839066]
[4]
Rohren EM, Turkington TG, Coleman RE. Clinical applications of PET in oncology. Radiology. 2004 May:231(2):305-32
[PubMed PMID: 15044750]
[5]
Otsuka H, Graham M, Kubo A, Nishitani H. Clinical utility of FDG PET. The journal of medical investigation : JMI. 2004 Feb:51(1-2):14-9
[PubMed PMID: 15000251]
[6]
Anagnostopoulos C, Georgakopoulos A, Pianou N, Nekolla SG. Assessment of myocardial perfusion and viability by positron emission tomography. International journal of cardiology. 2013 Sep 1:167(5):1737-49. doi: 10.1016/j.ijcard.2012.12.009. Epub 2013 Jan 11
[PubMed PMID: 23313467]
[7]
Jamar F, Buscombe J, Chiti A, Christian PE, Delbeke D, Donohoe KJ, Israel O, Martin-Comin J, Signore A. EANM/SNMMI guideline for 18F-FDG use in inflammation and infection. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2013 Apr:54(4):647-58. doi: 10.2967/jnumed.112.112524. Epub 2013 Jan 28
[PubMed PMID: 23359660]
[8]
Avril N. GLUT1 expression in tissue and (18)F-FDG uptake. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2004 Jun:45(6):930-2
[PubMed PMID: 15181126]
[9]
Suolinna EM, Haaparanta M, Paul R, Härkönen P, Solin O, Sipilä H. Metabolism of 2-[18F]fluoro-2-deoxyglucose in tumor-bearing rats: chromatographic and enzymatic studies. International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology. 1986:13(5):577-81
[PubMed PMID: 3818323]
[10]
Berger A. How does it work? Positron emission tomography. BMJ (Clinical research ed.). 2003 Jun 28:326(7404):1449
[PubMed PMID: 12829560]
[11]
Groheux D. Role of Fludeoxyglucose in Breast Cancer: Treatment Response. PET clinics. 2018 Jul:13(3):395-414. doi: 10.1016/j.cpet.2018.02.003. Epub 2018 May 7
[PubMed PMID: 30100078]
[12]
Liberti MV, Locasale JW. The Warburg Effect: How Does it Benefit Cancer Cells? Trends in biochemical sciences. 2016 Mar:41(3):211-218. doi: 10.1016/j.tibs.2015.12.001. Epub 2016 Jan 5
[PubMed PMID: 26778478]
[13]
Doyle WK, Budinger TF, Valk PE, Levin VA, Gutin PH. Differentiation of cerebral radiation necrosis from tumor recurrence by [18F]FDG and 82Rb positron emission tomography. Journal of computer assisted tomography. 1987 Jul-Aug:11(4):563-70
[PubMed PMID: 3496366]
[14]
Sarikaya I. PET studies in epilepsy. American journal of nuclear medicine and molecular imaging. 2015:5(5):416-30
[PubMed PMID: 26550535]
[15]
Graff-Radford NR, Jones DT. Normal Pressure Hydrocephalus. Continuum (Minneapolis, Minn.). 2019 Feb:25(1):165-186. doi: 10.1212/CON.0000000000000689. Epub
[PubMed PMID: 30707192]
[16]
Khalaf S, Chamsi-Pasha M, Al-Mallah MH. Assessment of myocardial viability by PET. Current opinion in cardiology. 2019 Sep:34(5):466-472. doi: 10.1097/HCO.0000000000000652. Epub
[PubMed PMID: 31393420]
Level 3 (low-level) evidence
[17]
Rosenbaum D, Millon A, Fayad ZA. Molecular imaging in atherosclerosis: FDG PET. Current atherosclerosis reports. 2012 Oct:14(5):429-37. doi: 10.1007/s11883-012-0264-x. Epub
[PubMed PMID: 22872371]
[18]
Alavi A, Kung JW, Zhuang H. Implications of PET based molecular imaging on the current and future practice of medicine. Seminars in nuclear medicine. 2004 Jan:34(1):56-69
[PubMed PMID: 14735459]
[19]
Minamimoto R, Takahashi N, Inoue T. FDG-PET of patients with suspected renal failure: standardized uptake values in normal tissues. Annals of nuclear medicine. 2007 Jun:21(4):217-22
[PubMed PMID: 17581720]
[20]
Zanotti-Fregonara P, Jan S, Taieb D, Cammilleri S, Trébossen R, Hindié E, Mundler O. Absorbed 18F-FDG dose to the fetus during early pregnancy. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2010 May:51(5):803-5. doi: 10.2967/jnumed.109.071878. Epub 2010 Apr 15
[PubMed PMID: 20395321]
[21]
Langen KJ, Braun U, Rota Kops E, Herzog H, Kuwert T, Nebeling B, Feinendegen LE. The influence of plasma glucose levels on fluorine-18-fluorodeoxyglucose uptake in bronchial carcinomas. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 1993 Mar:34(3):355-9
[PubMed PMID: 8441023]
[22]
Rabkin Z, Israel O, Keidar Z. Do hyperglycemia and diabetes affect the incidence of false-negative 18F-FDG PET/CT studies in patients evaluated for infection or inflammation and cancer? A Comparative analysis. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2010 Jul:51(7):1015-20. doi: 10.2967/jnumed.109.074294. Epub 2010 Jun 16
[PubMed PMID: 20554733]
Level 2 (mid-level) evidence
[23]
McIntosh LJ, Bankier AA, Vijayaraghavan GR, Licho R, Rosen MP. COVID-19 Vaccination-Related Uptake on FDG PET/CT: An Emerging Dilemma and Suggestions for Management. AJR. American journal of roentgenology. 2021 Oct:217(4):975-983. doi: 10.2214/AJR.21.25728. Epub 2021 Mar 1
[PubMed PMID: 33646823]
[24]
Eifer M, Tau N, Alhoubani Y, Kanana N, Domachevsky L, Shams J, Keret N, Gorfine M, Eshet Y. COVID-19 mRNA Vaccination: Age and Immune Status and Its Association with Axillary Lymph Node PET/CT Uptake. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2022 Jan:63(1):134-139. doi: 10.2967/jnumed.121.262194. Epub 2021 Apr 23
[PubMed PMID: 33893188]
[26]
Lee DY, Lee JJ, Kwon HS, Moon WY, Jin SY, Lee SJ, Oh SJ, Ryu JS. An unusual case of anaphylaxis after fluorine-18-labeled fluorodeoxyglucose injection. Nuclear medicine and molecular imaging. 2013 Sep:47(3):201-4. doi: 10.1007/s13139-013-0202-z. Epub 2013 Apr 25
[PubMed PMID: 24900108]
Level 3 (low-level) evidence
[27]
Brush J, Boyd K, Chappell F, Crawford F, Dozier M, Fenwick E, Glanville J, McIntosh H, Renehan A, Weller D, Dunlop M. The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation. Health technology assessment (Winchester, England). 2011 Sep:15(35):1-192, iii-iv. doi: 10.3310/hta15350. Epub
[PubMed PMID: 21958472]
Level 1 (high-level) evidence
[28]
Apostolova I, Lange C, Suppa P, Spies L, Klutmann S, Adam G, Grothe MJ, Buchert R, Alzheimer’s Disease Neuroimaging Initiative. Impact of plasma glucose level on the pattern of brain FDG uptake and the predictive power of FDG PET in mild cognitive impairment. European journal of nuclear medicine and molecular imaging. 2018 Jul:45(8):1417-1422. doi: 10.1007/s00259-018-3985-4. Epub 2018 Mar 3
[PubMed PMID: 29502311]
[29]
Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W, Verzijlbergen FJ, Barrington SF, Pike LC, Weber WA, Stroobants S, Delbeke D, Donohoe KJ, Holbrook S, Graham MM, Testanera G, Hoekstra OS, Zijlstra J, Visser E, Hoekstra CJ, Pruim J, Willemsen A, Arends B, Kotzerke J, Bockisch A, Beyer T, Chiti A, Krause BJ, European Association of Nuclear Medicine (EANM). FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. European journal of nuclear medicine and molecular imaging. 2015 Feb:42(2):328-54. doi: 10.1007/s00259-014-2961-x. Epub 2014 Dec 2
[PubMed PMID: 25452219]
[30]
Sprinz C, Zanon M, Altmayer S, Watte G, Irion K, Marchiori E, Hochhegger B. Effects of blood glucose level on 18F fluorodeoxyglucose (18F-FDG) uptake for PET/CT in normal organs: an analysis on 5623 patients. Scientific reports. 2018 Feb 1:8(1):2126. doi: 10.1038/s41598-018-20529-4. Epub 2018 Feb 1
[PubMed PMID: 29391555]
[31]
Slart RHJA, Writing group, Reviewer group, Members of EANM Cardiovascular, Members of EANM Infection & Inflammation, Members of Committees, SNMMI Cardiovascular, Members of Council, PET Interest Group, Members of ASNC, EANM Committee Coordinator. FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC. European journal of nuclear medicine and molecular imaging. 2018 Jul:45(7):1250-1269. doi: 10.1007/s00259-018-3973-8. Epub 2018 Apr 11
[PubMed PMID: 29637252]
[32]
Dai KS, Tai DY, Ho P, Chen CC, Peng WC, Chen ST, Hsu CC, Liu YP, Hsieh HC, Yang CC, Tsai MC, Mao SJ. Accuracy of the EasyTouch blood glucose self-monitoring system: a study of 516 cases. Clinica chimica acta; international journal of clinical chemistry. 2004 Nov:349(1-2):135-41
[PubMed PMID: 15469866]
Level 3 (low-level) evidence
[33]
Vali R, Alessio A, Balza R, Borgwardt L, Bar-Sever Z, Czachowski M, Jehanno N, Kurch L, Pandit-Taskar N, Parisi M, Piccardo A, Seghers V, Shulkin BL, Zucchetta P, Lim R. SNMMI Procedure Standard/EANM Practice Guideline on Pediatric (18)F-FDG PET/CT for Oncology 1.0. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2021 Jan:62(1):99-110. doi: 10.2967/jnumed.120.254110. Epub
[PubMed PMID: 33334912]
Level 1 (high-level) evidence